AAOS Now, March-April 2024
-
AAOS and FDA Prioritize Collaboration to Promote Medical Device Safety and Innovation
AAOS and the FDA both seek to further strengthen their working relationship by encouraging AAOS members who are considering submitting live educational events for the 2025 AAOS Annual Meeting programming to contact representatives from the FDA to discuss their topics and request FDA contributors when a federal regulatory perspective may add to the quality of the content.
-
Is Generative AI the Next Technology Transformation for Healthcare?
The symposium, titled “Generative Artificial Intelligence—A Technology Set to Transform Musculoskeletal Care?” was an exploration of generative AI and its risks, challenges, and opportunities in the healthcare arena. It included insights from several experts to help attendees navigate these topics.